In drug development, ACE remains a significant target for creating new treatments for cardiovascular diseases. Toxicologists contribute to this process by evaluating the safety and efficacy of potential drug candidates. By understanding how these compounds interact with ACE, researchers can optimize drug design to enhance therapeutic benefits while minimizing toxic side effects.
